• News
  • Media
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
Commentary|Podcasts|August 25, 2023

Pharmacy Focus: Dangers of Drug Diversion for Health Care Professionals

Tom Knight, founder and CEO of Invistics, now part of Wolters Kluwer, discusses the dangers of drug diversion and how this could negatively impact affect patients.

In this week's episode of Pharmacy Focus, Tom Knight, founder and CEO of Invistics, now part of Wolters Kluwer, discusses the dangers of drug diversion and how this could negatively impact affect patients and health care professionals.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Related Content